181 related articles for article (PubMed ID: 11273593)
1. Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease.
Lahiri DK; Farlow MR; Hintz N; Utsuki T; Greig NH
Acta Neurol Scand Suppl; 2000; 176():60-7. PubMed ID: 11273593
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.
Lahiri DK; Farlow MR; Nurnberger JI; Greig NH
Ann N Y Acad Sci; 1997 Sep; 826():416-21. PubMed ID: 9329715
[TBL] [Abstract][Full Text] [Related]
3. The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.
Lahiri DK; Farlow MR; Sambamurti K
Brain Res Mol Brain Res; 1998 Nov; 62(2):131-40. PubMed ID: 9813282
[TBL] [Abstract][Full Text] [Related]
4. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.
Lahiri DK; Lewis S; Farlow MR
J Neurosci Res; 1994 Apr; 37(6):777-87. PubMed ID: 8046778
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.
Lahiri DK; Alley GM; Tweedie D; Chen D; Greig NH
Neuromolecular Med; 2007; 9(2):157-68. PubMed ID: 17627035
[TBL] [Abstract][Full Text] [Related]
6. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.
Lahiri DK; Farlow MR
J Mol Neurosci; 1996; 7(1):41-9. PubMed ID: 8835781
[TBL] [Abstract][Full Text] [Related]
8. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
9. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K
Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490
[TBL] [Abstract][Full Text] [Related]
10. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
11. The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells.
Lahiri DK; Farlow MR; Sambamurti K; Nall C
Life Sci; 1997; 61(20):1985-92. PubMed ID: 9366505
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
Utsuki T; Yu QS; Davidson D; Chen D; Holloway HW; Brossi A; Sambamurti K; Lahiri DK; Greig NH; Giordano T
J Pharmacol Exp Ther; 2006 Aug; 318(2):855-62. PubMed ID: 16690718
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions.
Haroutunian V; Greig N; Pei XF; Utsuki T; Gluck R; Acevedo LD; Davis KL; Wallace WC
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):161-8. PubMed ID: 9191090
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
Darreh-Shori T; Hosseini SM; Nordberg A
J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
[TBL] [Abstract][Full Text] [Related]
15. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
Lahiri DK; Rogers JT; Greig NH; Sambamurti K
Curr Pharm Des; 2004; 10(25):3111-9. PubMed ID: 15544501
[TBL] [Abstract][Full Text] [Related]
16. Maturation and processing of the amyloid precursor protein is regulated by the potassium/sodium hyperpolarization-activated cyclic nucleotide-gated ion channel 2 (HCN2).
Frykman S; Inoue M; Ikeda A; Teranishi Y; Kihara T; Lundgren JL; Yamamoto NG; Bogdanovic N; Winblad B; Schedin-Weiss S; Tjernberg LO
Biochem Biophys Res Commun; 2017 Jan; 483(1):352-358. PubMed ID: 28017718
[TBL] [Abstract][Full Text] [Related]
17. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types.
Lahiri DK
J Pineal Res; 1999 Apr; 26(3):137-46. PubMed ID: 10231726
[TBL] [Abstract][Full Text] [Related]
18. Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons.
Bailey JA; Ray B; Greig NH; Lahiri DK
PLoS One; 2011; 6(7):e21954. PubMed ID: 21799757
[TBL] [Abstract][Full Text] [Related]
19. Activity of alpha-secretase as the common final effector of protein kinase C-dependent and -independent modulation of amyloid precursor protein metabolism.
Racchi M; Solano DC; Sironi M; Govoni S
J Neurochem; 1999 Jun; 72(6):2464-70. PubMed ID: 10349856
[TBL] [Abstract][Full Text] [Related]
20. Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein.
Fuller SJ; Storey E; Li QX; Smith AI; Beyreuther K; Masters CL
Biochemistry; 1995 Jun; 34(25):8091-8. PubMed ID: 7794922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
